Continuous infusion of macrophage inflammatory protein MIP-1CX enhances leucocyte recovery and haemopoietic progenitor cell mobilization after cyclophosphamide
1997
MIP-1a Enhances Recovery of Blood Cells After Chemotherapy
Sample size: 60
publication
Evidence: moderate
Author Information
Author(s): E Marshall, LB Woolford, BI Lord
Primary Institution: CRC Department of Medical Oncology, Christie Hospital, Manchester
Hypothesis
Does continuous infusion of MIP-1a improve recovery of blood cells after cyclophosphamide treatment?
Conclusion
MIP-1a enhances leucocyte recovery and progenitor cell release after cyclophosphamide treatment.
Supporting Evidence
- MIP-1a treatment resulted in a significant increase in CFU-S recovery after cyclophosphamide.
- Leucocyte recovery was faster in mice treated with MIP-1a compared to controls.
- Combining MIP-1a with G-CSF led to the most rapid recovery of blood cells.
Takeaway
MIP-1a helps the body recover blood cells faster after chemotherapy, making it easier for patients to heal.
Methodology
Mice were treated with cyclophosphamide and received continuous infusion of MIP-1a to assess recovery of blood cells.
Limitations
The study was conducted in mice, which may not fully represent human responses.
Participant Demographics
Female B6D2F1 mice aged 10 weeks were used.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website